Recursion Overview
- Founded
- 2013
- Status
- Public
- Employees
- 214
- Stock Symbol
- RXRX
- Investments
- 1
- Share Price
- $7.09
- (As of Monday Closing)
Recursion General Information
Description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
- 41 South Rio Grande Street
- Salt Lake City, UT 84101
- United States
+1 (385) 000-0000
Recursion Timeline
Recursion Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.09 | $7.65 | $7.01 - $42.81 | $1.29B | 169M | 1.47M | -$1.33 |
Recursion Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|
| EV | 3,259,550 | ||
| Revenue | 10,336 | 3,962 | 2,319 |
| EBITDA | (137,722) | (81,540) | (59,442) |
| Net Income | (147,312) | (87,006) | (61,879) |
| Total Assets | 658,606 | 298,585 | 101,431 |
| Total Debt | 5,620 | 15,662 | 16,169 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Recursion Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.
Request a free trialRecursion Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.
Request a free trialRecursion Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technolog
Drug Discovery
Salt Lake City, UT
214
As of 2021
00000
0.000
0000-00-00
00000000
00000
0000000
um dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
0000000000000
Branford, CT
00000000
um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000 000000000
Nottingham, United Kingdom
000
As of 0000
00000000000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialRecursion Competitors (23)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioXcel | Corporation | Branford, CT | ||||
| 000000000 00000000 | Private Equity-Backed | Nottingham, United Kingdom | 000 | 00000000000 | ||
| 00 000000000000 | Venture Capital-Backed | Guilford, CT | 00 | 0000 | 000000000 - | 0000 |
| 000000000000 | Private Equity-Backed | London, United Kingdom | 000 | 00000 | 000000000 | 00000 |
| 0000000 | Venture Capital-Backed | Toronto, Canada | 00 | 000.00 | 00000 | 000.00 |
Recursion Patents
Recursion Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10743109-B1 | Ordered picklist for liquid transfer | Active | 10-Mar-2020 | 00000000 | |
| US-20210071256-A1 | Systems and methods for pairwise inference of drug-gene interaction networks | Pending | 11-Sep-2019 | 000000000 | |
| US-20200402628-A1 | Systems and methods for evaluating query perturbations | Pending | 19-Jun-2019 | 00000000 | |
| US-20200342189-A1 | Method of receiving rfid signals from multiple transponders | Abandoned | 27-Apr-2019 | 0000000000 | |
| US-20200342188-A1 | Device for receiving rfid signals from multiple transponders | Abandoned | 27-Apr-2019 | A01K1/031 |
Recursion Executive Team (23)
Recursion Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alaa Halawa | Mubadala Investment Company | Board Observer | 000 0000 |
| Blake Borgeson Ph.D | Recursion | Founder & Board Member | 000 0000 |
| Dean Li Ph.D | Recursion | Co-Founder & Board Member | 000 0000 |
| James Hardiman | DCVC | Board Observer | 000 0000 |
| Lee Cooper JD | Self | Board Observer | 000 0000 |
Recursion Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRecursion Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Recursion‘s full profile, request access.
Request a free trialRecursion Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000 | 28-Jul-2020 | 0000000000 | Discovery Tools (Healthcare) | 000000000 |
Recursion Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000 | Discovery Tools (Healthcare) | San Mateo, CA | 0000 |